Clinical Trial Update: Growth Hormone and Exclusion Diet Therapy in Juvenile Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating growth hormone plus an exclusion diet for juvenile Crohn's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Columbia University | Conditions: Crohn's Disease | Phase 2 | Status: WITHDRAWN